Inactive

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Cancer Genetics Branch (CGB), Genomics core p... The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Cancer Genetics Branch (CGB), Genomics core plans to procure, on a sole source basis, preventative maintenance service for a government-owned equipment Illumina NextSeq 2000 Serial Number: VH01509 from: Illumina, Inc 5200 Illumina Way San Diego CA 92122-4616 The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 811210 and the business size standard is $34.0 million. This equipment is manufactured by Illumina, Inc. Illumina is the only known service provider for the scientific equipment to be serviced under the contract. The equipment is highly specialized and complicated, integrating many proprietary technologies. Illumina is the only provider of service by factory trained engineers, and the only provider of original grade replacement parts. It is critical for the research community that the equipment mentioned above is calibrated accurately and maintained according to the manufacturer’s specifications. Any deviation from the specifications could ruin countless hours of work, distort and destroy the integrity of information and/or ruin further studies, and significantly delay the laboratory's throughput. The software supplied with this equipment is proprietary, and updates and patches are solely available through Illumina. They have unlimited access to parts and technical support both of which are of a proprietary nature. Illumina, Inc. is the Original Equipment Manufacturer (OEM) therefore: • Can provide OEM generated software and hardware component updates/revisions as they are released by the OEM, at no additional cost to the Government. • Can provide immediate access to a full range of OEM replacement parts. • Has sufficient knowledge of multiple, complex OEM-designed/installed modifications on the Cancer Genetics Branch’s equipment that specifically satisfy requirement. • Can provide toll-free telephone trouble shooting and email support that includes the latest OEM knowledge and recommendations by certified factory trained engineers. This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contract Specialist, David Romley, at David.Romley@nih.gov no later than 12:00 P.M. EST on Thursday, March 6, 2025 (3/6/2025). A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91025Q00017 on all correspondence. ***Please reference attached Statement of Work for more details pertaining to the nature of the work to be performed.***